NOREPINEPHRINE BITARTRATE — norepinephrine bitartrate injection, solution
Cantrell Drug Company
Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only.
To facilitate Adverse Event Reporting: www.fda.gov/medwatch or 1-800-FDA-1088.
Norepinephrine bitartrate injection solution is supplied as a sterile, nonpyrogenic solution that is clear, colorless at 250 mL in a Single-Dose Injection Solution Bag.
This product is Preservative-Free and Latex-Free.
Each 1 mL contains the equivalent of 64 mcg norepinephrine base, 50 mg dextrose, 473.6 mcg sodium chloride, 128 mcg sodium metabisulfite, and pH adjusters include hydrochloric acid and/or sodium hydroxide, if necessary.
Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from light.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit.
Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains a precipitate.
FOR INTRAVENOUS USE ONLY. PRESERVATIVE-FREE INJECTION SOLUTION.
CANTRELL DRUG COMPANY
LITTLE ROCK, AR 72207
| NOREPINEPHRINE BITARTRATE |
norepinephrine bitartrate injection, solution
|Labeler — Cantrell Drug Company (035545763)|
Revised: 03/2015 Cantrell Drug Company
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.